Currently, a short calcitonin and CEA doubling time (<6 months) are considered the best available indicators to assess tumour behaviour, MTC recurrence and cancer mortality (Barbet et al. 2005, Laure Giraudet et al. 2008). Here, CALCA is linked to neoplasm.